XML 56 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Restricted Stock, Restricted Stock Units Activity and SAR's (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Payment Arrangement, Expense $ 1,282 $ 513 $ 3,291 $ 1,703  
Weighted Average Grant Date Fair Value          
Common stock, shares, outstanding (in shares) 157,607,156   157,607,156   156,262,199
Common stock, shares, issued (in shares) 157,607,156   157,607,156   156,262,199
Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 157,607,156 at September 30, 2022 and 156,262,199 at December 31, 2021 $ 696,808   $ 696,808   $ 685,903
Equity Option          
Weighted Average Grant Date Fair Value          
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 1.34 $ 0.94 $ 0.94
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 4.13   $ 4.13   $ 1.34
Employee Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Payment Arrangement, Expense $ 98 42 $ 239 $ 281  
Weighted Average Grant Date Fair Value          
Unrecognized Compensation Costs Related To Unvested Stock Options     300    
Restricted Stock Units (RSUs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Payment Arrangement, Expense $ 618 409 $ 1,589 $ 1,162  
Number of Shares          
Granted, nonvested, number of shares (in shares)     410,000 440,000  
Weighted Average Grant Date Fair Value          
Unrecognized Compensation Costs Related To R S U Awards     $ 1,530    
Restricted Stock Units (RSUs) | Equity Option          
Number of Shares          
Number of nonvested shares, beginning of period (in shares)     900,064 1,094,056 1,094,056
Granted, nonvested, number of shares (in shares)     411,467   441,241
Vested, number of shares (in shares)     (518,856)   (635,233)
Forfeited, number of shares (in shares)     (45,250)    
Number of nonvested shares, end of period (in shares) 747,425   747,425   900,064
Weighted Average Grant Date Fair Value          
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 2.94 $ 1.98 $ 1.98
Granted, nonvested, weighted average grant date fair value (in dollars per share)     6.52   3.89
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     5.40    
Vested, weighted average grant date fair value (in dollars per share)     2.93   1.94
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 4.77   $ 4.77   $ 2.94
Stock Appreciation Rights (SARs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Payment Arrangement, Expense $ 566 $ 62 $ 1,463 $ 260  
Number of Shares          
Number of nonvested shares, beginning of period (in shares)     1,672,422 1,720,623 1,720,623
Granted, nonvested, number of shares (in shares)     833,315    
Exercised, number of shares (in shares)     (6,730)   (48,201)
Forfeited, number of shares (in shares)     (46,239)    
Number of nonvested shares, end of period (in shares) 2,452,768   2,452,768   1,672,422
Weighted Average Grant Date Fair Value          
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 2.92 $ 2.92 $ 2.92
Granted, nonvested, weighted average grant date fair value (in dollars per share)     6.47    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised, Weighted Average Exercise Price     2.92   2.92
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     5.95    
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 4.07   $ 4.07   $ 2.92
Unrecognized Compensation Costs Related To R S U Awards     $ 1,680    
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number 1,092,143   1,092,143    
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price $ 2.92   $ 2.92    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms     2 years 3 months 14 days    
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Term     1 year 3 months 21 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $ 5,309   $ 5,309    
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value $ 3,495   $ 3,495    
Stock Appreciation Rights (SARs) | Equity Option          
Number of Shares          
Number of nonvested shares, beginning of period (in shares)     573,549 1,720,623 1,720,623
Granted, nonvested, number of shares (in shares)     833,315    
Vested, number of shares (in shares)         (1,147,074)
Forfeited, number of shares (in shares)     (46,239)    
Number of nonvested shares, end of period (in shares) 1,360,625   1,360,625   573,549
Weighted Average Grant Date Fair Value          
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)     $ 1.19 $ 1.25 $ 1.25
Granted, nonvested, weighted average grant date fair value (in dollars per share)     3.99    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     4.13    
Vested, weighted average grant date fair value (in dollars per share)         1.27
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 2.81   $ 2.81   $ 1.19